Generalized morphea after COVID-19 vaccines: a case series.
作者信息
Paolino G, Campochiaro C, Di Nicola M R, Mercuri S R, Rizzo N, Dagna L, Rongioletti F, De Luca G
机构信息
Unità di Dermatologia Clinica, Vita-Salute San Raffaele University, Milan, Italy.
Unit of Dermatology and Cosmetology, IRCCS San Raffaele Hospital, Milan, Italy.
出版信息
J Eur Acad Dermatol Venereol. 2022 Sep;36(9):e680-e682. doi: 10.1111/jdv.18249. Epub 2022 May 31.
Abstract
摘要
相似文献
1
Generalized morphea after COVID-19 vaccines: a case series.新冠疫苗接种后的泛发性硬斑病：病例系列
J Eur Acad Dermatol Venereol. 2022 Sep;36(9):e680-e682. doi: 10.1111/jdv.18249. Epub 2022 May 31.
2
Generalized morphea following the COVID vaccine: A series of two patients and a bibliographic review.COVID 疫苗接种后泛发性硬斑病：两例患者系列病例及文献复习。
Dermatol Ther. 2022 Sep;35(9):e15709. doi: 10.1111/dth.15709. Epub 2022 Jul 20.
3
A Case of Morphea After COVID-19 Vaccination.1例新冠疫苗接种后硬斑病病例。
Dermatitis. 2024 Mar-Apr;35(2):187-188. doi: 10.1089/derm.2023.0120. Epub 2023 Aug 22.
4
Morphea and COVID-19 mRNA vaccine.硬斑病与新冠mRNA疫苗
Int J Dermatol. 2022 May;61(5):e162. doi: 10.1111/ijd.16156. Epub 2022 Mar 1.
5
A case of morphea following the COVID-19 mRNA vaccine: on the basis of viral spike proteins.1例新型冠状病毒肺炎mRNA疫苗接种后硬斑病：基于病毒刺突蛋白
Int J Dermatol. 2022 May;61(5):639-641. doi: 10.1111/ijd.16062. Epub 2022 Jan 24.
6
Acid-fast bacteria in scleroderma and morphea.硬皮病和局限性硬皮病中的抗酸菌。
Arch Dermatol. 1971 Jul;104(1):21-5.
7
Morphoea following COVID-19 vaccination.接种 COVID-19 疫苗后的硬斑病。
Clin Exp Dermatol. 2022 Dec;47(12):2293-2295. doi: 10.1111/ced.15349. Epub 2022 Sep 21.
8
Scleroderma: nomenclature, etiology, pathogenesis, prognosis, and treatments: facts and controversies.硬皮病：命名、病因、发病机制、预后和治疗：事实和争议。
Clin Dermatol. 2013 Jul-Aug;31(4):432-437. doi: 10.1016/j.clindermatol.2013.01.010.
9
Localized scleroderma: clinical spectrum and therapeutic update.局限性硬皮病：临床谱与治疗进展
An Bras Dermatol. 2015 Jan-Feb;90(1):62-73. doi: 10.1590/abd1806-4841.20152890.
10
Unilateral multisegmental morphea.
Cutis. 2011 Jul;88(1):41-2.
引用本文的文献
1
Linear Morphea in the Context of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Unique Dermatological Manifestation.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染背景下的线状硬皮病：一种独特的皮肤表现。
Cureus. 2024 Mar 27;16(3):e57031. doi: 10.7759/cureus.57031. eCollection 2024 Mar.
2
Eosinophilic fasciitis following COVID-19: A case series of 3 patients.新型冠状病毒肺炎后嗜酸性筋膜炎：3例病例系列
JAAD Case Rep. 2023 Dec 6;44:6-10. doi: 10.1016/j.jdcr.2023.11.019. eCollection 2024 Feb.
3
The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature.COVID-19 疫苗接种对炎症性皮肤疾病和其他皮肤疾病的影响：已发表文献综述。
Viruses. 2023 Jun 23;15(7):1423. doi: 10.3390/v15071423.
4
Generalized morphea induced by the COVID-19 vaccine in a patient with chronic urticaria.新冠疫苗诱发慢性荨麻疹患者出现泛发性硬斑病。
Dermatol Reports. 2022 Dec 23;15(2):9632. doi: 10.4081/dr.2023.9632. eCollection 2023 Jun 7.
5
Generalized morphea following COVID-19 vaccine: Case report and literature review.新冠疫苗接种后泛发性硬斑病：病例报告及文献综述
Clin Case Rep. 2023 Mar 30;11(4):e7133. doi: 10.1002/ccr3.7133. eCollection 2023 Apr.
6
The clinical and pathologic spectrum of mucocutaneous reactions after COVID-19 vaccinations in three tertiary referral centers of northern Italy.意大利北部三家三级转诊中心的 COVID-19 疫苗接种后黏膜皮肤反应的临床和病理谱。
Clin Dermatol. 2023 Mar-Apr;41(2):312-319. doi: 10.1016/j.clindermatol.2023.02.001. Epub 2023 Feb 28.
7
Morphea: The 2023 update.硬斑病：2023年更新版
Front Med (Lausanne). 2023 Feb 13;10:1108623. doi: 10.3389/fmed.2023.1108623. eCollection 2023.
8
Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature.新冠疫苗接种后的皮肤反应：当前文献综述
Clin Cosmet Investig Dermatol. 2022 Nov 6;15:2369-2382. doi: 10.2147/CCID.S388245. eCollection 2022.
本文引用的文献
1
Palmoplantar lichenoid drug eruption following the administration of Pfizer-BioNTech COVID-19 vaccine.接种辉瑞-BioNTech新冠疫苗后出现掌跖苔藓样药疹。
JAAD Case Rep. 2022 Mar;21:182-184. doi: 10.1016/j.jdcr.2022.01.014. Epub 2022 Jan 24.
2
A case of morphea following the COVID-19 mRNA vaccine: on the basis of viral spike proteins.1例新型冠状病毒肺炎mRNA疫苗接种后硬斑病：基于病毒刺突蛋白
Int J Dermatol. 2022 May;61(5):639-641. doi: 10.1111/ijd.16062. Epub 2022 Jan 24.
3
Morphea induced by SARS-CoV-2 infection: A case report.由严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染引起的硬斑病：一例报告。
Int J Dermatol. 2022 Mar;61(3):377-378. doi: 10.1111/ijd.15983. Epub 2021 Nov 15.
4
Pansclerotic Morphea Following COVID-19: A Case Report and Review of Literature on Rheumatologic and Non-rheumatologic Dermatologic Immune-Mediated Disorders Induced by SARS-CoV-2.新型冠状病毒肺炎后泛硬化性硬斑病：1例报告及关于严重急性呼吸综合征冠状病毒2诱导的风湿性和非风湿性皮肤免疫介导疾病的文献综述
Front Med (Lausanne). 2021 Oct 20;8:728411. doi: 10.3389/fmed.2021.728411. eCollection 2021.
5
Cutaneous findings following COVID-19 vaccination: review of world literature and own experience.接种 COVID-19 疫苗后的皮肤表现：世界文献复习和自身经验。
J Eur Acad Dermatol Venereol. 2022 Feb;36(2):172-180. doi: 10.1111/jdv.17744. Epub 2021 Nov 2.
6
Cutaneous vasculitis following COVID-19 vaccination.新冠病毒疫苗接种后发生的皮肤血管炎。
Lancet Rheumatol. 2021 Nov;3(11):e743-e744. doi: 10.1016/S2665-9913(21)00309-X. Epub 2021 Sep 30.
7
COVID-19 vaccines: modes of immune activation and future challenges.COVID-19 疫苗：免疫激活模式和未来挑战。
Nat Rev Immunol. 2021 Apr;21(4):195-197. doi: 10.1038/s41577-021-00526-x.
8
Morphea and Extragenital Lichen Sclerosus et Atrophicus After Influenza Vaccination.流感疫苗接种后出现的硬斑病和外生殖器外硬化性苔藓萎缩症
Actas Dermosifiliogr (Engl Ed). 2018 Jan-Feb;109(1):86-88. doi: 10.1016/j.ad.2017.05.016. Epub 2017 Oct 10.
9
Updates on morphea: role of vascular injury and advances in treatment.硬斑病的最新进展：血管损伤的作用及治疗进展
Autoimmune Dis. 2013;2013:467808. doi: 10.1155/2013/467808. Epub 2013 Nov 12.
10
Morphea in adults and children cohort III: nested case-control study--the clinical significance of autoantibodies in morphea.成人和儿童硬斑病队列 III：巢式病例对照研究——硬斑病中自身抗体的临床意义。
JAMA Dermatol. 2013 Oct;149(10):1159-65. doi: 10.1001/jamadermatol.2013.4207.
Zotero 插件